Regel Therapeutics Names Stephen J. Farr as New CEO
Regel Therapeutics’ Board of Directors has named Stephen J. Farr, PhD, as the new Chief Executive Officer (CEO).
Genetic Disorders | 21/06/2024 | By Aishwarya | 379
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy